Heartflow (NASDAQ:HTFL) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Key Points

• Robert W. Baird raised its Heartflow price target from $56 to $68 and maintained an “outperform” rating, implying 13.48% upside from the stock’s price at the time of the report. Analysts’ consensus rating was “Moderate Buy,” with a $51.50 average target.
• Heartflow beat third-quarter estimates: revenue rose 57% year over year to $72.9 million, and its $0.03-per-share loss was narrower than expected. The company also raised its 2026 revenue outlook to $262 million–$264 million, above consensus.
• Company insiders sold a combined 332,403 shares worth about $16.6 million over three months; the CEO and CFO sales were made under pre-arranged Rule 10b5-1 plans.

Heartflow (NASDAQ:HTFL - Get Free Report) had its price target raised by Robert W. Baird from $56.00 to $68.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an "outperform" rating on the stock. Robert W. Baird's price target would indicate a potential upside of 13.48% from the stock's current price.

A number of other brokerages have also recently issued reports on HTFL. Canaccord Genuity Group lifted their target price on Heartflow from $45.00 to $56.00 and gave the stock a "buy" rating in a report on Tuesday, September 22nd. Stifel Nicolaus upped their target price on Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a report on Friday, August 14th. Wells Fargo & Company increased their price target on Heartflow from $37.00 to $39.00 and gave the company an "overweight" rating in a research report on Friday, August 14th. JPMorgan Chase & Co. lifted their price target on Heartflow from $35.00 to $45.00 and gave the stock an "overweight" rating in a research note on Friday, August 14th. Finally, Piper Sandler restated an "overweight" rating and set a $64.00 price objective (up from $45.00) on shares of Heartflow in a report on Tuesday, October 20th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $51.50.

Heartflow Stock Performance

Heartflow stock opened at $59.92 on Friday. Heartflow has a 1 year low of $20.13 and a 1 year high of $60.65. The firm's 50 day moving average price is $51.93 and its two-hundred day moving average price is $35.14.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The company had revenue of $72.86 million during the quarter. During the same quarter last year, the company posted ($0.27) EPS. Equities research analysts forecast that Heartflow will post -0.75 earnings per share for the current year.

Insiders Place Their Bets

In other Heartflow news, CEO John Farquhar sold 38,900 shares of the business's stock in a transaction on Monday, October 12th. The shares were sold at an average price of $49.57, for a total transaction of $1,928,273.00. Following the sale, the chief executive officer directly owned 283,014 shares of the company's stock, valued at $14,029,003.98. The trade was a 12.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Vikram Verghese sold 29,714 shares of the business's stock in a transaction on Friday, September 11th. The shares were sold at an average price of $50.06, for a total transaction of $1,487,482.84. Following the sale, the chief financial officer directly owned 184,789 shares in the company, valued at approximately $9,250,537.34. This trade represents a 13.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 332,403 shares of company stock worth $16,602,786. Corporate insiders own 7.70% of the company's stock.

Institutional Investors Weigh In On Heartflow

Several hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC grew its stake in Heartflow by 75.1% during the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company's stock valued at $32,000 after acquiring an additional 275 shares in the last quarter. IFP Advisors Inc lifted its position in shares of Heartflow by 844.7% in the third quarter. IFP Advisors Inc now owns 803 shares of the company's stock worth $40,000 after purchasing an additional 718 shares in the last quarter. Allworth Financial LP lifted its position in shares of Heartflow by 116.4% in the third quarter. Allworth Financial LP now owns 1,145 shares of the company's stock worth $57,000 after purchasing an additional 616 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new stake in shares of Heartflow during the second quarter worth approximately $53,000. Finally, Essential Partners LLC acquired a new stake in shares of Heartflow during the first quarter worth approximately $57,000.

Key Stories Impacting Heartflow

These are some of the HTFL stories that stood out recently:

• Positive Sentiment: Third-quarter revenue rose 57% year over year to $72.9 million, exceeding the roughly $65.2 million analyst estimate. The loss was $0.03 per share, narrower than both the expected $0.18 loss and the $0.27 loss a year earlier. HeartFlow Reports Q3 Loss, Beats Revenue Estimates
• Positive Sentiment: Heartflow raised its 2026 revenue guidance to $262 million–$264 million, above the approximately $248.6 million consensus estimate. The higher outlook may signal stronger growth expectations. Heartflow Expects 2026 Revenue of $262M–$264M
• Negative Sentiment: CEO insider selling may weigh on sentiment: the CEO sold $2.17 million of Heartflow stock. A sale by itself does not establish the reason for the transaction. Heartflow CEO Sells $2.17 Million in Stock

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient's coronary arteries and provide information that can support diagnosis and treatment planning. The company's offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.